To view the PDF file, sign up for a MySharenet subscription.

FERRUM CRESCENT LIMITED - Completion of Fundraising

Release Date: 08/11/2017 09:30
Code(s): FCR     PDF:  
Wrap Text
Completion of Fundraising

FERRUM CRESCENT LIMITED
(Incorporated and registered in Australia and registered as an external company
in the Republic of South Africa)
(Registration number A.C.N. 097 532 137)
(External company registration number 2011/116305/10)
Share code on the ASX: FCR
Share code on AIM: FCR
Share code on the JSE: FCR
Australian ISIN: AU000000WRL8
South African ISIN: AU000000FCR2



8 November 2017

                         Ferrum Crescent Limited
              (“FCR”, the “Company” or the “Group”) (ASX, AIM, JSE: FCR)

                           Completion of Fundraising

FCR, the European lead-zinc explorer, is pleased to announce that the placement,
via Beaufort Securities Limited as AIM broker for the Company, of 370,499,858 fully
paid new ordinary shares at an issue price of 0.05 pence per share (the “Placing
Shares”), as announced on 2 November 2017 (the “Placing”), has now been
completed. The Placing raised, in aggregate, approximately GBP185,250 (before
expenses).

The Placing Shares were issued to Mr Colin Bird and certain of his associates,
including African Pioneer Plc, without shareholder approval utilising the Company's
existing placement capacity under ASX Listing Rule 7.1.

The net proceeds from the Placing will be used by the Company to support its
ongoing lead-zinc exploration programme in North West Spain and for general
working capital purposes.

An Appendix 3B and Cleansing Notice are attached.

Information required under ASX Listing Rule 3.10.5A

(a) Dilution to existing shareholders as a result of the Placing is as follows:

       Details                                                   Issued Shares    Dilution

       Number of shares on issue prior to the Placing             2,684,781,581   N/A

       Placing issue under ASX Listing Rule 7.1                     370,499,858   12.127%

       Number of shares on issue following the Placing            3,055,281,439   N/A


   The securities issued under Listing Rule 7.1 have been issued to both existing
   and new security holders. The percentages of the post-Placing capital are as
   follows:

       •   87.88% held by pre-Placing security holders who did not participate in the
           Placing;

       •   5.23% held by pre-Placing security holders who did participate in the
           Placing;

       •   6.89% held by participants in the Placing who were not previously security
           holders.


(b) The Company issued 370,499,858 shares under ASX Listing Rule 7.1 as a
    placement which was considered to be the most efficient and expedient means
    by which to raise funds in the current circumstances. The Placing did not expose
    FCR to additional costs, a protracted process and market volatility that may have
    been experienced with a pro rata issue or other type of issue in which existing
    ordinary security holders would have been eligible to participate.

(c) A fee of up to 5% may be paid to brokers/advisers in connection with the Placing.



For further information on the Company, please visit www.ferrumcrescent.com or
www.fcrexploration.com or contact:

Ferrum Crescent Limited
Grant Button, Chairman (Australia)
T: +61 8 9474 2995
Laurence Read, Executive Director (UK)
T: +44 (0)20 3289 9923

Strand Hanson Limited (Nominated Adviser)
Rory Murphy/Matthew Chandler
T: +44 (0)20 7409 3494

Beaufort Securities Limited (Broker)
Elliot Hance
T: +44 (0)20 7382 8300

Peterhouse Corporate Finance Limited (Broker)
Lucy Williams / Duncan Vasey / Heena Karani
T: +44 (0)20 7469 0930

Bravura Capital (Pty) Ltd (JSE Sponsor)
Melanie De Nysschen
T (direct): +27 11 459 5052

The information contained within this announcement is deemed by the Company to constitute
inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014.
                                                                                     

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

                                New issue announcement,
                     application for quotation of additional securities
                                      and agreement

Information or documents not available now must be given to ASX as soon as available. Information
and documents given to ASX become ASX’s property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05,
01/08/12, 04/03/13




Name of entity

Ferrum Crescent Limited (the Company)


ABN

58 097 532 137


We (the entity) give ASX the following information.




Part 1 - All issues
You must complete the relevant sections (attach sheets if there is not enough space).


1          Class of securities issued or to            Fully Paid Ordinary Shares
           be issued



2          Number of securities issued or               370,499,858 shares issued pursuant to a
           to be issued (if known) or                    placement via Beaufort Securities as agent for
           maximum number which may be                   the Company (Placing Shares)
           issued



3          Principal terms of the securities            Fully Paid Ordinary Shares
           (e.g. if options, exercise price and
           expiry date; if partly paid
           securities,        the     amount
           outstanding and due dates for
           payment;         if     convertible
           securities, the conversion price
           and dates for conversion)

4          Do the securities rank equally in           The Placing Shares rank equally in all respects
           all respects from the issue date            with ordinary fully paid shares on issue.
           with an existing class of quoted
           securities?


     If the additional securities do
     not rank equally, please state:

     • the date from which they do
     • the extent to which they
         participate for the next
         dividend, (in the case of a
         trust, distribution) or interest
         payment
     • the extent to which they do
         not rank equally, other than in
         relation to the next dividend,
         distribution     or     interest
         payment


5    Issue price or consideration
                                            GBP 0.0005 per share



6    Purpose of the issue
                                            The funds raised from the issue of the Placing
     (If issued as consideration for the
                                            Shares will be used to support the Company's
     acquisition of assets, clearly
                                            on-going lead-zinc exploration programme in
     identify those assets)
                                            northwest Spain and for general working capital
                                            purposes.




6a   Is the entity an eligible entity      Yes
     that has obtained security holder
     approval under rule 7.1A?

     If Yes, complete sections 6b – 6h
     in relation to the securities the
     subject of this Appendix 3B, and
     comply with section 6i


6b   The date the security holder
                                           30 November 2016
     resolution under rule 7.1A was
     passed


6c   Number of securities issued           370,499,858
     without security holder approval
     under rule 7.1


6d   Number of securities issued                     Nil
     with security holder approval
     under rule 7.1A
6e   Number of securities issued                     Nil
     with security holder approval
     under rule 7.3, or another specific
     security holder approval (specify
     date of meeting)



6f   Number of securities issued                     Nil
     under an exception in rule 7.2


6g   If securities issued under rule                 N/A
     7.1A, was issue price at least 75%
     of 15 day VWAP as calculated
     under rule 7.1A.3? Include the
     issue date and both values.
     Include the source of the VWAP
     calculation.


6h   If securities were issued under                 N/A
     rule    7.1A     for    non-cash
     consideration, state date on
     which valuation of consideration
     was released to ASX Market
     Announcements


6i   Calculate the entity’s remaining
                                                      Listing Rule 7.1 - 32,217,379
     issue capacity under rule 7.1 and
     rule 7.1A – complete Annexure 1                  Listing Rule 7.1A - 53,695,632
     and release to ASX Market
     Announcements


7    Issue dates
                                                      8 November 2017
     Note: The issue date may be prescribed by ASX
     (refer to the definition of issue date in rule
     19.12). For example, the issue date for a pro
     rata entitlement issue must comply with the
     applicable timetable in Appendix 7A.

     Cross reference: item 33 of Appendix 3B.




                                           Number                   Class

8    Number and  class                    3,052,981,439            Ordinary shares
     of all securities quoted on ASX
     (including the securities in
     section 2 if applicable)
     
                                                      
                    
                                          Number                    Class

9    Number and class of all
     securities not quoted on ASX
                                          2,300,000                 Ordinary shares
                                                                    issued under the
     (including the securities in                                  terms of the Ferrum
     section 2 if applicable)                                       Crescent Share Plan


                                                                    GBP0.0075 options
                                                                    expiring 2 February
                                          2,000,000
                                                                    2018


                                                                    GBP0.02 options
                                                                    expiring 2 February
                                                                    2018
                                          3,000,000

                                                                    GBP0.0075 options
                                                                    expiring 1 March 2018


                                          2,000,000                 GBP0.02 options
                                                                    expiring 1 March 2018


                                                                    GBP0.00165 options
                                                                    expiring 12 May 2018
                                          3,000,000

                                                                    GBP0.003 options
                                                                    expiring 29 July 2018


                                          197,411,127




                                          205,949,134



10   Dividend policy (in the case of a
                                          There is currently no dividend policy in place for
     trust, distribution policy) on the
                                          the Company.
     increased capital (interests)


Part 2 - Pro rata issue

  11   Is security holder approval
                                                       N/A
       required?



  12   Is the issue renounceable or non-
                                                       N/A
       renounceable?


  13   Ratio in which the securities will
                                                       N/A
       be offered


  14   Class  of securities to which the
                                                       N/A
       offer relates


  15   Record date to determine
                                                       N/A
       entitlements



  16   Will holdings on different
                                                       N/A
       registers (or subregisters) be
       aggregated for calculating
       entitlements?


  17   Policy for deciding entitlements in
                                                       N/A
       relation to fractions



  18   Names of countries in which the
                                                       N/A
       entity has security holders who
       will not be sent new offer
       documents
       Note: Security holders must be told how their
       entitlements are to be dealt with.

       Cross reference: rule 7.7.



  19   Closing date for receipt  of
                                                       N/A
       acceptances or renunciations

  20   Names of any underwriters
                                                       N/A



  21   Amount of any underwriting fee
                                                       N/A
       or commission


  22   Names of any brokers to the issue
                                                       N/A
  23      Fee or commission payable to the
                                                       N/A
          broker to the issue


  24      Amount of any handling fee
                                                       N/A
          payable to brokers who lodge
          acceptances or renunciations on
          behalf of security holders


  25      If the issue is contingent on
                                                       N/A
          security holders’ approval, the
          date of the meeting


  26      Date entitlement and acceptance
                                                       N/A
          form and offer documents will be
          sent to persons entitled


  27      If the entity has issued options,
                                                       N/A
          and the terms entitle option
          holders to participate on exercise,
          the date on which notices will be
          sent to option holders


  28      Date rights trading will begin (if
                                                       N/A
          applicable)


  29      Date rights trading will end (if
                                                       N/A
          applicable)




  30      How do security holders sell their
                                                       N/A
          entitlements in full through a
          broker?


  31      How do security holders sell part
                                                       N/A
          of their entitlements through a
          broker and accept for the balance?


  32      How do security holders dispose
                                                       N/A
          of their entitlements (except by
          sale through a broker)?


  33      Issue   date
                                                       N/A




Part 3 - Quotation of securities
You need only complete this section if you are applying for quotation of securities
  
   34      Type of securities
          (tick one)

            (a)              Securities    described in Part 1



            (b)              All other securities
                             Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid,
                             employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible
                             securities




Entities that have ticked box 34(a)

Additional securities forming a new class of securities



Tick to indicate you are providing the information or
documents


  35            If the securities are equity securities the number the names of the 20 largest holders of the
                additional securities, and the number and percentage of additional securities held by those holders

  36            If the securities are equity securities, a distribution schedule of the additional securities 
                setting out the number of holders in the categories

                   1 - 1,000
                   1,001 - 5,000
                   5,001 - 10,000
                   10,001 - 100,000
                   100,001 and over

  37             copy of any trust deed for the additional securities




Entities that have ticked box 34(b)

  38      Number of securities for which
          quotation is sought
                                                             N/A



  39      Class  of securities for which
          quotation is sought                                N/A
          
  40      Do the securities rank equally in
                                                             N/A
         all respects from the issue date
         with an existing class of quoted
         securities?


         If the additional securities do not
         rank equally, please state:

         • the date from which they do
         • the extent to which they
             participate for the next
             dividend, (in the case of a trust,
             distribution) or interest
             payment
         • the extent to which they do not
             rank equally, other than in
             relation to the next dividend,
             distribution or interest
             payment


    41   Reason for request for quotation
         now                                                  N/A
         
         Example: In the case of restricted securities, end
         of restriction period (if issued upon conversion of
         another security, clearly identify
         that other security)


      




                                                              Number      Class

    42   Number and  class
         of all securities
         quoted  on ASX 
         (including the securities in clause
         38)                                                     N/A         N/A
        




Quotation agreement


1        Quotation of our additional securities is in ASX’s absolute discretion. ASX may
         quote the securities on any conditions it decides.


2        We warrant the following to ASX.


       •       The issue of the securities to be quoted complies with the law and is not
               for an illegal purpose.
       •       There is no reason why those securities should not be granted quotation.


       •       An offer of the securities for sale within 12 months after their issue will not
               require disclosure under section 707(3) or section 1012C(6) of the
               Corporations Act.
               Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be

               able to give this warranty




       •       Section 724 or section 1016E of the Corporations Act does not apply to any

               applications received by us in relation to any securities to be quoted and

               that no-one has any right to return any securities to be quoted under

               sections 737, 738 or 1016F of the Corporations Act at the time that we

               request that the securities be quoted.




       •       If we are a trust, we warrant that no person has the right to return the
               securities to be quoted under section 1019B of the Corporations Act at the

               time that we request that the securities be quoted.


3      We will indemnify ASX to the fullest extent permitted by law in respect of any claim,
       action or expense arising from or connected with any breach of the warranties in
       this agreement.


4      We give ASX the information and documents required by this form. If any
       information or document is not available now, we will give it to ASX before
       quotation of the securities begins. We acknowledge that ASX is relying on the

       information and documents. We warrant that they are (will be) true and complete.




Sign here:                                                                            Date: 8 November 2017
               Company secretary
Print name:    Grant Button
Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible
entities
Introduced 01/08/12 Amended 04/03/13



Part 1

                        Rule 7.1 – Issues exceeding 15% of capital

   Step 1: Calculate “A”, the base figure from which the placement
   capacity is calculated

   Insert number of fully paid ordinary           1,868,632,922
   securities on issue 12 months before the
   issue date or date of agreement to issue


   Add the following:                              769,231 (25 November 2016)

   •   Number of fully paid ordinary              3,205,088 (22 December 2016)
       securities issued in that 12 month
       period under an exception in rule 7.2       275,218,025 (22 December 2016)

   •   Number of fully paid ordinary              322,173,789 (23 June 2017)
       securities issued in that 12 month
       period with shareholder approval            214,782,526 (14 September 2017)

   •   Number of partly paid ordinary
       securities that became fully paid in that
       12 month period

   Note:
   •   Include only ordinary securities here –
       other classes of equity securities
       cannot be added
   •   Include here (if applicable) the
       securities the subject of the Appendix
       3B to which this form is annexed
   •   It may be useful to set out issues of
       securities on different dates as
       separate line items
   Subtract the number of fully paid               0
   ordinary securities cancelled during that

   12 month period

   “A”                                             2,684,781,581
Step 2: Calculate 15% of “A”

“B”                                             0.15



Multiply “A” by 0.15                            402,717,237

Step 3: Calculate “C”, the amount of placement capacity under rule
7.1 that has already been used

Insert number of equity securities issued
or agreed to be issued in that 12 month
period not counting those issued:               370,499,858 (8 November 2017)

•   Under an exception in rule 7.2

•   Under rule 7.1A

•   With security holder approval under
    rule 7.1 or rule 7.4

Note:
•   This applies to equity securities, unless
    specifically excluded – not just ordinary
    securities
•   Include here (if applicable) the
    securities the subject of the Appendix
    3B to which this form is annexed
•   It may be useful to set out issues of
    securities on different dates as
    separate line items
“C”                                             370,499,858

Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1

“A” x 0.15                                      402,717,237

Note: number must be same as shown in
Step 2

Subtract “C”                                    370,499,858

Note: number must be same as shown in
Step 3

Total [“A” x 0.15] – “C”                        32,217,379
Part 2

        Rule 7.1A – Additional placement capacity for eligible entities

  Step 1: Calculate “A”, the base figure from which the placement
  capacity is calculated

  “A”                                              2,684,781,581

  Note: number must be same as shown in
  Step 1 of Part 1

  Step 2: Calculate 10% of “A”

  “D”                                              0.10



  Multiply “A” by 0.10                             268,478,158

  Step 3: Calculate “E”, the amount of placement capacity under rule
  7.1A that has already been used

  Insert number of equity securities issued       214,782,526 (14 September 2017)
  or agreed to be issued in that 12 month
  period under rule 7.1A

  Notes:
  •   This applies to equity securities – not
      just ordinary securities
  •   Include here – if applicable – the
      securities the subject of the Appendix
      3B to which this form is annexed
  •   Do not include equity securities issued
      under rule 7.1 (they must be dealt with
      in Part 1), or for which specific security
      holder approval has been obtained
  •   It may be useful to set out issues of
      securities on different dates as
      separate line items
  “E”                                              214,782,526
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A

“A” x 0.10                              268,478,158

Note: number must be same as shown in
Step 2

Subtract “E”                            214,782,526

Note: number must be same as shown in
Step 3

Total [“A” x 0.10] – “E”                53,695,632




                                                               15
8 November 2017

Company Announcements Office
ASX Limited
Level 40
Central Park
152-158 St Georges Terrace
PERTH WA 6000


Notice under section 708A(5)(e) of the Corporations Act 2001 (Cth)

This notice is given by Ferrum Crescent Limited ACN 097 532 137 (Ferrum Crescent or the
Company) under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Corporations Act).

On 2 November 2017, Ferrum Crescent announced the placement of 370,499,858 new fully
paid ordinary shares of no par value in the capital of the Company (the Placing Shares).

The Placing Shares were issued today at a price of GBP0.0005 per share to raise up to
approximately GBP185,250 (before costs).

For the purposes of section 708A(6) of the Corporations Act, Ferrum Crescent advises that:

(a) the Placing Shares have been issued without disclosure to investors under Part 6D.2 of the
    Corporations Act;

(b) as at the date of this notice, Ferrum Crescent has complied with:
        (i) the provisions of Chapter 2M of the Corporations Act as they apply to Ferrum
             Crescent; and
        (ii) section 674 of the Corporations Act; and

(c) as at the date of this notice, there is no excluded information of the type referred to in
    sections 708A(7) and 708A(8) of the Corporations Act.

Yours sincerely



Grant Button
Company Secretary




                                                                                             16






Date: 08/11/2017 09:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story